INSM
Insmed Incorporated Healthcare - Biotechnology Investor Relations →
Insmed Incorporated (INSM) closed at $136.00 as of 2026-03-20, trading 119.1% above its 200-week moving average of $62.06. The stock is currently moving closer to the line, down from 126.9% last week. With a 14-week RSI of 20, INSM is in oversold territory.
Over the past 14 weeks, down-weeks have had more trading volume than up-weeks (0.66 buyers-vs-sellers ratio). That means when people are active, they're more often selling than buying. Sellers are still more in control than buyers.
Over the past 1298 weeks of data, INSM has crossed below its 200-week moving average 24 times. On average, these episodes lasted 32 weeks. Historically, investors who bought INSM at the start of these episodes saw an average one-year return of +37.5%.
With a market cap of $29.3 billion, INSM is a large-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -249.3%. The stock trades at 39.4x book value.
Share count has increased 57.9% over three years, indicating dilution.
Over the past 24.9 years, a hypothetical investment of $100 in INSM would have grown to $232, compared to $809 for the S&P 500. INSM has returned 3.4% annualized vs 8.8% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: INSM vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After INSM Crosses Below the Line?
Across 24 historical episodes, buying INSM when it crossed below its 200-week moving average produced an average return of +36.2% after 12 months (median +20.0%), compared to +13.8% for the S&P 500 over the same periods. 54% of those episodes were profitable after one year. After 24 months, the average return was +76.8% vs +29.0% for the index.
Each line shows $100 invested at the moment INSM crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
INSM has crossed below its 200-week MA 24 times with an average 1-year return of +37.5% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 2001 | Dec 2005 | 242 | 93.4% | -43.8% | +236.6% |
| Apr 2006 | Apr 2006 | 1 | 5.9% | -42.2% | +719.3% |
| May 2006 | Apr 2009 | 153 | 68.4% | -53.0% | +719.3% |
| Jun 2009 | Feb 2010 | 33 | 31.8% | -33.3% | +1273.7% |
| May 2010 | Apr 2011 | 47 | 40.1% | +10.4% | +1558.5% |
| Aug 2011 | Nov 2012 | 67 | 65.7% | -15.0% | +3291.5% |
| Nov 2012 | Mar 2013 | 16 | 18.9% | +126.3% | +1799.4% |
| Jan 2016 | Feb 2017 | 58 | 35.1% | +15.7% | +924.9% |
| Mar 2017 | Mar 2017 | 1 | 1.0% | +37.2% | +760.2% |
| May 2017 | Jun 2017 | 4 | 3.6% | +71.8% | +746.3% |
| Jul 2017 | Sep 2017 | 5 | 28.9% | +84.7% | +860.5% |
| Sep 2018 | Sep 2018 | 1 | 0.3% | -1.5% | +612.0% |
| Oct 2018 | Jan 2019 | 14 | 39.1% | +1.9% | +687.9% |
| Jul 2019 | Nov 2019 | 15 | 18.2% | +50.0% | +681.2% |
| Jan 2020 | Jan 2020 | 1 | 0.7% | +109.1% | +577.0% |
| Mar 2020 | Apr 2020 | 6 | 31.0% | +91.3% | +565.4% |
| May 2021 | Jun 2021 | 3 | 5.2% | -21.7% | +426.1% |
| Jul 2021 | Aug 2021 | 5 | 10.1% | -7.9% | +461.1% |
| Nov 2021 | Dec 2021 | 1 | 0.8% | -21.3% | +425.3% |
| Jan 2022 | Aug 2022 | 30 | 29.8% | -28.2% | +428.2% |
| Aug 2022 | Sep 2023 | 55 | 35.4% | -13.5% | +441.2% |
| Sep 2023 | Nov 2023 | 9 | 7.1% | +187.0% | +438.6% |
| Mar 2024 | Mar 2024 | 1 | 1.3% | +197.6% | +428.8% |
| Apr 2024 | May 2024 | 6 | 15.4% | +198.7% | +459.2% |
| Average | 32 | — | +37.5% | — |
Frequently Asked Questions
Is INSM below its 200-week moving average?
No. Insmed Incorporated (INSM) is currently 119.1% above its 200-week moving average of $62.06. It would need to fall to $62.06 to cross below the line.
What is INSM's 200-week moving average price?
Insmed Incorporated's 200-week moving average is $62.06 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when INSM drops below its 200-week moving average?
INSM has crossed below its 200-week moving average 24 times in our data. On average, buying at that moment produced a one-year return of +37.5%. These dips have historically been decent entry points. These episodes lasted 32 weeks on average.
Is INSM a good value right now?
Here's what our data says about INSM as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 20 (oversold). Free cash flow is currently negative. Return on equity is -249.3%. Price-to-book is 39.4x. This is not a buy or sell recommendation — always do your own research.
How does INSM compare to the S&P 500?
Over the past 24.9 years, $100 invested in INSM would have grown to $232, compared to $809 for the S&P 500. That's 3.4% annualized vs 8.8% for the index. INSM has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20